Anti-OCLN/ BLCPMG/ PPP1R115 monoclonal antibody

Anti-OCLN/ BLCPMG/ PPP1R115 antibody for FACS & in-vivo assay

Target products collectionGo to OCLN/OCLN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0916-Ab-1/ GM-Tg-hg-MP0916-Ab-2Anti-Human OCLN monoclonal antibodyHuman
GM-Tg-rg-MP0916-Ab-1/ GM-Tg-rg-MP0916-Ab-2Anti-Rat OCLN monoclonal antibodyRat
GM-Tg-mg-MP0916-Ab-1/ GM-Tg-mg-MP0916-Ab-2Anti-Mouse OCLN monoclonal antibodyMouse
GM-Tg-cynog-MP0916-Ab-1/ GM-Tg-cynog-MP0916-Ab-2Anti-Cynomolgus/ Rhesus macaque OCLN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0916-Ab-1/ GM-Tg-felg-MP0916-Ab-2Anti-Feline OCLN monoclonal antibodyFeline
GM-Tg-cang-MP0916-Ab-1/ GM-Tg-cang-MP0916-Ab-2Anti-Canine OCLN monoclonal antibodyCanine
GM-Tg-bovg-MP0916-Ab-1/ GM-Tg-bovg-MP0916-Ab-2Anti-Bovine OCLN monoclonal antibodyBovine
GM-Tg-equg-MP0916-Ab-1/ GM-Tg-equg-MP0916-Ab-2Anti-Equine OCLN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0916-Ab-1/ GM-Tg-hg-MP0916-Ab-2; GM-Tg-rg-MP0916-Ab-1/ GM-Tg-rg-MP0916-Ab-2;
GM-Tg-mg-MP0916-Ab-1/ GM-Tg-mg-MP0916-Ab-2; GM-Tg-cynog-MP0916-Ab-1/ GM-Tg-cynog-MP0916-Ab-2;
GM-Tg-felg-MP0916-Ab-1/ GM-Tg-felg-MP0916-Ab-2; GM-Tg-cang-MP0916-Ab-1/ GM-Tg-cang-MP0916-Ab-2;
GM-Tg-bovg-MP0916-Ab-1/ GM-Tg-bovg-MP0916-Ab-2; GM-Tg-equg-MP0916-Ab-1/ GM-Tg-equg-MP0916-Ab-2
Products NameAnti-OCLN monoclonal antibody
Formatmab
Target NameOCLN
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OCLN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species OCLN/ BLCPMG/ PPP1R115 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001093human OCLN Lentivirus particle
    ORF Viral VectorpGMLP001093human OCLN Lentivirus plasmid
    ORF Viral VectorpGMLPm005039mouse Ocln Lentivirus plasmid
    ORF Viral VectorvGMLPm005039mouse Ocln Lentivirus particle


    Target information

    Target IDGM-MP0916
    Target NameOCLN
    Gene ID100506658,18260,83497,700504,403844,101089577,512405,100073306
    Gene Symbol and SynonymsBLCPMG,Ocl,OCLN,PPP1R115,PTORCH1
    Uniprot AccessionQ16625,Q6P6T5,Q28269
    Uniprot Entry NameOCLN_HUMAN,OCLN_RAT,OCLN_CANLF
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197822
    Target ClassificationN/A

    The target: OCLN, gene name: OCLN, also named as BLCPMG, PPP1R115, PTORCH1. This gene encodes an integral membrane protein that is required for cytokine-induced regulation of the tight junction paracellular permeability barrier. Mutations in this gene are thought to be a cause of band-like calcification with simplified gyration and polymicrogyria (BLC-PMG), an autosomal recessive neurologic disorder that is also known as pseudo-TORCH syndrome. Alternative splicing results in multiple transcript variants. A related pseudogene is present 1.5 Mb downstream on the q arm of chromosome 5. [provided by RefSeq, Apr 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.